Clearing Psoriasis With High-Dose Vitamin D

By Erik Goldman

Baseline and post-treatment images of a 58-year-old woman with longstanding psoriasis vulgaris, treated with high-dose vitamin D3 for two months. (Mahtani R, Nair PMK. Clin Immunol Comm. 2023)

A small but compelling case series published last year suggests that mega-doses of vitamin D can yield dramatic improvement in the severity of longstanding psoriasis. And by “mega,” we mean doses as high as 60,000 IU per day.

Renu Mahtani, a physician at the Autoimmunity Treatment Centre, Pune, India, together with Pradeep M.K. Nair of the Sant Hirdaram Medical College of Naturopathy in Bhopal, treated six patients—five women and one man—with high-dose oral vitamin D (25-hydroxy cholecalciferol) for periods of 2-6 months, in the absence of other concomitant psoriasis therapies.

The patients ranged in age from 48 to 63 years, and all had moderate to severe psoriasis for between 2-30 years. Three had psoriasis vulgaris, and the others had the palmoplantar form of the disease.

[ ...Read More ]

Featured Articles

The Post-Viral Recovery Program Supplement Protocols

Written by Erik Goldman

The Long Covid nutritional protocol developed by the 10-member practitioner working group under the aegis of OvationLab and ANDHealth, is divided into two parts—Foundational Supplements aimed at improving overall health, and Specialty Supplements focused on the five main drivers of Long Covid: ACE2-mediated tissue damage; viral persistence; chronic inflammation; mitochondrial dysfunction; and microbiome/dysbiosis. The working […]

[ ...Read More ]

Leveraging the Power of Probiotics To Treat Liver Disease

Written by Erik Goldman

Probiotics could be an important piece of the therapeutic puzzle for people with hepatic cirrhosis and other forms of progressive liver disease. Research from around the world is shedding light on the so-called “gut-liver axis” and the ways in which the gut microbiome affects liver function, both negatively and positively.  This work opens up promising […]

[ ...Read More ]

HPC Video

Nutritional Support for Post-Menopausal Osteoarthritis

Written by Erik Goldman

According to the American College of Obstetricians & Gynecologists, there are roughly 27 million American women in the peri- to post-menopausal years–that’s 20% of the US work force. And each year, roughly 2 million American women reach menopause.

Women betwen the ages of 50-60 years have a 3.5-fold higher risk of osteoarthritis than men of the same age. OA in post-menopausal women tends to be more severe and affects more joints.

In this free webinar, Dr. Anita Baxas, MD D.PSc, explores the relationship of bone and cartilage remodeling to OA in the menopausal milieu, and the role of Bone Morphogenic Proteins (BMPs) in supporting menopausal women at risk for OA.

Many clinicians do not recognize the cross-talk between dysregulated subchondral bone and cartilage, and the cascading impact it has on their post-menopausal patients.  Learn how bone remodeling dysregulation influences the joint micro-environment, leading to the onset and exacerbation of OA in post-menopausal women.

During this webinar Dr. Baxas will share: 

  • Factors that alter the articular joint micro-environment.
  • Insights on the structure and function of BMPs within Bone & Cartilage homeostasis.
  • The dual immodulating and osteoinductive effects of BMPs
  • Clinical experiences using Ostinol® in her osteoporosis treatments.
  • Case Studies
  • Personal practice protocol for post-menopausal OA

Sponsored by : REGENERATIVE TISSUE SCIENCE

[ ...Read More ]